Searchable abstracts of presentations at key conferences in endocrinology

ea0039ep107 | Pituitary and growth | BSPED2015

Manifestations of overt diabetes on GH treatment

Madhusudhana M , Mathew V , Marrow J , Willingham L , Gupta S

GH therapy has been reported to increase insulin resistance, but overt diabetes is rare. We present a young girl who developed symptoms of diabetes whilst on GH therapy with resolution of symptoms and normalisation of blood glucose profile on reducing the dose of GH.Case report: A 14-year-old girl with background of prematurity, learning difficulty, cerebral palsy, scoliosis, and pan hypopituitarism presented with chest infection, high blood glucose leve...

ea0038p30 | Clinical biochemistry | SFEBES2015

Audit of management of patients with hypomagnesaemia in district general hospital

Tofeec K , Pichaipillai L , Bani T , Jostel A , Demssie Y

Background: Hypomagnesaemia is one of the most commonly encountered electrolyte disorders in clinical practice. The reported prevalence of hypomagnesaemia varies from 2.5 to 15% in the general population to as high as 65% among patients admitted to intensive care units. There is a general lack of awareness among physicians regarding the prevalence, clinical significance, and management of hypomagnesaemia.Aim and method: To review current practice of the ...

ea0035p20 | Adrenal cortex | ECE2014

Measurement of serum total cortisol using HPLC coupled ESI–TOF mass spectrometry

Tarjanyi Zita , Montsko Gergely , Mezosi Emese , Kovacs Gabor L

Cortisol is a glucocorticoid hormone with low molecular weight (362 Da) synthesized from cholesterol in the adrenal gland. The release is regulated by the hypothalamic–pituitary-adrenal (HPA) axis. Approximately 95% of the circulating amount is bound to proteins (CBG and albumin), but only the remaining free fraction is biologically active. Serum cortisol level is routinely analysed in laboratory medicine, though the widespread immunoassays (RIA and ECLIA) have the disadv...

ea0070aep23 | Adrenal and Cardiovascular Endocrinology | ECE2020

Mortality in patients with adrenal incidentalomas and autonomous cortisol secretion

Kjellbom Albin , Olsen Henrik , Lindgren Ola , Löndahl Magnus

Background: Autonomous cortisol secretion (ACS) in patients with adrenal incidentalomas (AI) has been associated with increased mortality in previous small studies. Our aim was to evaluate if ACS is a risk factor for mortality in a large population of patients with AI.Methods: Consecutive patients examined for adrenal adenomas, found as AI, without catecholamine or aldosterone hypersecretion between 2005 and 2015 were included and followed for up to 14 y...

ea0026p176 | Neuroendocrinology | ECE2011

Hypothalamic neuropeptide Y controls the hepatic secretion of VLDL triglycerides in rats via the sympathetic nervous system

Bruinstroop E , Pei L , Ackermans M , Fliers E , Kalsbeek A

During fasting neuropeptide Y (NPY) neurons in the mediobasal hypothalamus are activated to increase food intake and to conserve energy. Under conditions of food deprivation, lipid metabolism plays an important role in providing fuel for muscle. We investigated if central NPY affects VLDL-TAG secretion directly via the autonomic nervous system. We measured VLDL-TAG secretion in Wistar rats by an intravenous bolus of tyloxapol to inhibit uptake of triglycerides by peripheral ti...

ea0026p641 | Clinical case reports | ECE2011

Multiple pituitary deficiencies in a young patient with primary empty sella

Rusu A , Cristea C , Gheorghiu L , Balcan R , Mogos V

Introduction: Usually, the hormonal profile is normal in patients with empty sella. However, when present, hormonal deficiency most commonly consist in growth disturbance in children and mild hyperprolactinaemia in adults. Hypopititarism with signs of symptomatic dysfunction occurs in <10% of patient with primary empty sella.Case report: A 27-years-old man presented to our department in 2008 with impuberism, micropenis, hypoplasic scrotum, inguinal g...

ea0005p86 | Diabetes, Metabolism and Cardiovascular | BES2003

Autosomal dominant neurohypophyseal diabetes insipidus associated with a glutatmine47 deletion

Alcocer L , Boxer M , Connell J , Ahmed S

We describe a 3 year old Scottish girl with polyuria and nocturia and a past history of congenital heart disease. In addition to her excess fluid intake she had reduced food intake, failure to thrive and growth failure. Her sister, father, grandfather and a paternal aunt and uncle had a clear history of polyuria, nocturia and excess thirst. A fluid deprivation test revealed peak serum Na, serum and urine osmolalities were 147 mmol/L, 300 mOs/kg, 176 mOs/kg, respectively, in th...

ea0004p24 | Clinical case reports | SFE2002

HYPOTHALAMIC DYSFUNCTION IN SHAPIRO'S SYNDROME MAY CAUSE ABNORMALITIES OF THIRST AND APPETITE PERCEPTION

Albon L , Kenton A , MacGregor E , Pall H , Gittoes N

Shapiro's syndrome is characterised by agenesis of the corpus callosum, hypothermia and hyperhydrosis. We report a case associated with abnormal water balance and hypothalamic dysfunction.A 20 year old Turkish Cypriot man presented with an 8 month history of profuse sweating associated with a perception of extreme cold. He described progressive problems with speech, memory and clumsiness on walking. Symptoms of polyuria and polydipsia were associated wit...

ea0003p12 | Clinical Case Reports | BES2002

The perils of low dose locally delivered steroids

Browne D , Cummings M , Murdoch S , Cook L , Meeking D

Clinical practice suggests that low dose steroid treatment delivered locally to the site of action may rarely lead to disturbances of the hypothalamic-pituitary-adrenal axis. We present three clinical examples:Case 1: A 72 yr old man with a history of severe sinusitis was referred because of three episodes of profound anorexia, vomiting and proximal muscle weakness which coincided with discontinuing his Betnesol (betamethasone sodium phosphate 0.1%) nose...

ea0003p57 | Clinical Case Reports | BES2002

The use of the domperidone test in differentiating macroprolactinaemia from true hyperprolactinaemia

Pinto L , Evans M , Hanna F , Scanlon M

Macroprolactin is a complex of prolactin with immunoglobulin appearing to have limited biological activity, partly due to failure of this high-molecular weight complex to cross capillary walls.Macroprolactinaemia is a common phenomenon, it is thus important to identify this condition in order to avoid unnecessary investigations and treatment. Although the presence of macroprolactin can be confirmed by gel filtration chromatography, this is time consumin...